Publication | Closed Access
Pentadecapeptide BPC 157 attenuates chronic amphetamine-induced behavior disturbances.
28
Citations
0
References
2002
Year
In summary, gastric pentadecapeptide BPC 157 (ie, both microg- and ng-BPC 157 regimens) attenuated chronic amphetamine disturbances. This effect was present throughout the observation period at a statistically significant level. Therefore, it seems that this gastric pentadecapeptide BPC 157 has a modulatory effect on dopamine system, and it could be used in chronic amphetamine disturbances.